BiotechnologyChemicalsEnergyHealthcareInformation TechnologyOther IndustriesPharmaceuticals

Global Gene Therapy for Age-related Macular Degeneration Market Report 2019 7ᵗʰ edition Top Companies, Sales, Revenue, Forecast and Detailed Analysis

April 2019, Global Gene Therapy for Age-related Macular Degeneration Market Report 2019 7ᵗʰ edition Top Companies, Sales, Revenue, Forecast and Detailed Analysis

Global Gene Therapy for Age-related Macular Degeneration Market Report 2019 7ᵗʰ edition  Top Companies, Sales, Revenue, Forecast and Detailed Analysis
Global Gene Therapy for Age-related Macular Degeneration Market Report 2019 7ᵗʰ edition Top Companies, Sales, Revenue, Forecast and Detailed Analysis
We have recently published  7ᵗʰ Edition market research report on Gene Therapy for Age-related Macular Degeneration. For purchase inquiry and free sample pages email us at: sales@marketreportscompany.com

 

Gene Therapy for Age-related Macular Degeneration market report is based on present industry situations, market demands, business strategies utilized by prominent players involved in this market along with their growth synopsis. This report has been segmented into types, applications and regions. The report also comprises major drivers boosting this market. Gene Therapy for Age-related Macular Degeneration market worth about XX million USD in 2018 and it is expected to reach YY million USD in 2026 with a CAGR of AA% during the forecast period.

 

Apply Here, Request Free Report Sample Pages:

 

http://marketreportscompany.com/contact.php

Macular degeneration is a condition in which, macula, a part of the retina, gets damaged or deteriorated. This condition usually affects individuals who are aged 50 years and above and therefore, it is called age-related macular degeneration (AMD). AMD is the leading cause of vision loss and is directly related to the advancement of age. But smoking also plays a vital role in causing AMD. AMD is characterized by the presence of a blurred area near the center of vision that leads to distorted vision. There are two different types of AMD, including dry (atrophic) AMD (dAMD) and wet (neovascular/exudative) AMD (wAMD). The dAMD is the most common type of AMD and accounts for almost 80%-90% of the overall AMD cases.

 

● Scope of the Report:

This report studies the Gene Therapy for Age-related Macular Degeneration market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Gene Therapy for Age-related Macular Degeneration market by product type and applications/end industries.

It has been observed that age-related macular degeneration (AMD) is one of the major causes for vision loss and is characterized by the formation of a blurred area near the center of vision, a condition that mostly affects the geriatric population. According to the CDC, almost 2 million individuals in the US suffer from AMD and by 2050, this number will reach more than 5 million. This will subsequently demand the need for the development of innovative treatments for AMD, driving the market’s growth.

The market research analysts have predicted that with the introduction of techniques such as fluorescein angiography, the global age-related macular degeneration market will register a CAGR of more than 7% by 2020. With the unavailability of FDA-approved treatment for dry AMD (dAMD) and the treatment of wet AMD (wAMD) involving the need of intravitreal injections for an indefinite period, gene therapy is emerging as the most-efficient approach for the treatment of age-related macular degeneration (AMD).

According to this pipeline analysis report, most of the gene therapy molecules in the pipeline are being developed for wet AMD (wAMD). Our market research analysts have also identified that most of these molecules are in the pre-clinical development stage and a considerable number of molecules have been discontinued from development.

The global Gene Therapy for Age-related Macular Degeneration market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Gene Therapy for Age-related Macular Degeneration.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

 

Market Segment by Companies, this report covers

● RetroSense Therapeutics

● REGENXBIO

● AGTC

 

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

 

Market Segment by Type, covers

● Subretinal

● Intravitreal

● Unspecified

 

Market Segment by Applications, can be divided into

● Monotherapy

● Combination Therapyhttp://marketreportscompany.com/contact.php

 

Leading Companies and Manufacturers Analysis of Gene Therapy for Age-related Macular Degeneration Market:

Company profiling of all top players involved in the Gene Therapy for Age-related Macular Degeneration market is available in the report. Profiling of any another specific player /competitor can also be provided as a part of report customization. Gene Therapy for Age-related Macular Degeneration market report provides the past, present and future industry trends and the forecast information related to the expected Gene Therapy for Age-related Macular Degeneration sales revenue, growth, demand and supply scenario. Furthermore, the opportunities and the threats to the development of Gene Therapy for Age-related Macular Degeneration market are also covered at depth in this research document. Report includes manufacturing analysis of the market. Global Gene Therapy for Age-related Macular Degeneration Market report offers evaluation of competitive landscape based on analysis of leading manufacturers from exhaustive research, notably on questions of vendors in the market which have been discovered through extensive analysis.

Gene Therapy for Age-related Macular Degeneration Industry Regional Coverage and Insights:

Geographically Gene Therapy for Age-related Macular Degeneration market report divided into some major key regions, with sales data (volume), revenue data (Million $$ USD), share data and growth rate of the industry for mentioned regions. Report covers the market in North America (United States, Canada, Mexico), Asia-Pacific (China, India, Japan, South Korea, Australia, Indonesia, Singapore), Europe (Germany, Russia, France, UK, Italy, Spain), Central & South America (Brazil, Argentina, Colombia), and Middle East & Africa (Saudi Arabia, Turkey, GCC, Nigeria).

********Prior Purchase, Request Free Report Sample Pages here:

http://marketreportscompany.com/contact.php

 

Table of Content:

Global Gene Therapy for Age-related Macular Degeneration Market Size, Status and Forecast 2026

1 Industry Overview of Global Gene Therapy for Age-related Macular Degeneration

2 Global Gene Therapy for Age-related Macular Degeneration Competition Analysis by Players

3 Company (Top Players) Profiles

4 Global Gene Therapy for Age-related Macular Degeneration Market Size by Type and Application (2014-2018)

5 Development Status and Outlook…

11 Market Forecast by Regions, Type and Application (2018-2026)

12 Global Gene Therapy for Age-related Macular Degeneration Market Dynamics

12.1 Global Gene Therapy for Age-related Macular Degeneration Industry News

12.2 Global Gene Therapy for Age-related Macular Degeneration Industry Development Challenges

12.3 Global Gene Therapy for Age-related Macular Degeneration Industry Development Opportunities (2018-2026)

13 Market Effect Factors Analysis

14 Global Gene Therapy for Age-related Macular Degeneration Market Forecast (2018-2026)

15 Research Finding/Conclusion

16 Appendix…………………….to receive complete Table of Content email us at sales@marketreportscompany.com

 

Key Highlights of the Gene Therapy for Age-related Macular Degeneration Market Report:

Historic study of market segments and sub-segments will help the readers in planning the business strategies. The key details related to Gene Therapy for Age-related Macular Degeneration industry like the demand and supply statistics product definition, cost, variety of applications are covered in this report

Competitive study of the major players will help all the market players in analyzing the latest trends and business strategies

Global Production Market Share of Gene Therapy for Age-related Macular Degeneration market by Types and by Applications in 2019

Furthermore, Worldwide Gene Therapy for Age-related Macular Degeneration Market 2019 represents industry enlargement game plan, the industry data source, appendix, research findings, and the conclusion.

Gene Therapy for Age-related Macular Degeneration Market Report gives a diligent survey of leading players in the market along with their annual proceeds; manufacturing company profiles, contact information such as phone number or email address, different business game plans of the market, their input to the market. Moreover, the report also features other contradictory characters that include import/export details, supply chain outlines, manufacturing guidelines, key developments, consumer volume, business overview and industry gross margin.

 

********Request Full TOC and Free Report Sample Pages here:

 

http://marketreportscompany.com/contact.php

 

What does Report Include?

Historic Data: What was the Gene Therapy for Age-related Macular Degeneration Market data (Size, competition, company share, YoY growth rate, etc.) from 2013 to 2018.

Current Market Status: A comprehensive analysis of current market Size, trends, growth drivers, industry pitfalls, challenges and opportunities for players.

Market Forecast: Report will comment and provide details about market growth and forecast till year 2026.

Customization: We can provide following things 1) On request more company profiles (competitors) 2) Data about particular country or region 3) We will incorporate the same with no additional cost (Post conducting feasibility).

 

About us: http://marketreportscompany.com/about-us.php

Contact Us:

Jason Smith,

Sales Manager, Global Business Development,

Website: marketreportscompany.com

Email: jasonsmith@marketreportscompany.com

Phone: +1-312-376-8303

Address: 20 N State Street,

Chicago, Illinois, 60602

United States.

 

**********************Download Report ***************************

 

Tags

Steve Fuller

I am proficient analyst with nearly 10 years’ experience providing critical market intelligence across any domain. I am also providing clients with strategic insight on current and emerging sectors in the global market. Wide knowledge of market research and active involvement in preparing segmentation analysis, competitive analysis is strengthening my position.

Related Articles

Close